Kei Sakamoto, a Programme Leader in the MRC Protein Phosphorylation Unit will become the Head of a new Division of Diabetes Research at the Nestle Institute of Health Sciences in Lausanne Switzerland. Kei, who has also been appointed to a Professorship at the Swiss Federal Institute of Technology, will take up his new post on March 1st 2012. Six members of Kei's research team will be moving with him to Lausanne and Kei will make nine more appointments over the next couple of years. In Lausanne, Kei will continue to elucidate the molecular mechanisms that control glucose and energy homeostasis with the aim of identifying novel drug targets aimed at treating metabolic disorders such as type 2 diabetes.
Commenting on Kei's new appointment, Sir Philip Cohen, the Director of the MRC Protein Phosphorylation Unit said:- 'Kei has done a great job for our Unit during the eight years that he has been with us. In addition to carrying out ground-breaking research of his own and important collaborative projects with other members of the Unit, he was also instrumental in setting up the Unit's state-of-the-art Molecular Physiology Laboratory. The huge promotion that Kei has now received is therefore very well deserved and we all wish him every success for the future.
Commenting on his new appointment Kei said:- 'I would particularly like to thank Professor Dario Alessi and Sir Philip Cohen for their tremendous support during my research career in Dundee, which was absolutely essential for me to become an independent and established investigator. The MRC Protein Phosphorylation Unit provides such an extraordinary stimulating, interactive and outstanding research environment with the state-of-art facilities, but I have decided to take on a new challenge and will make every effort to achieve breakthroughs in basic and translational research at the Nestle Institute in Lausanne.'
The Nestlé Institute of Health Sciences is based on the campus of the Swiss Federal Institute of Technology in Lausanne and part of Nestlé's global Research & Development network. It is fully funded by Nestlé, who will contribute 500 million Swiss francs to its development over the next 10 years. The mission of the Institute is [i]"To create and deliver world class excellence in biomedical research to better understand human health and ageing as influenced by genetics, metabolism and environment with the goal of translating this knowledge into personalized science-based nutrition".[/i] In Lausanne, Kei will continue to elucidate the molecular mechanisms that control glucose and energy homeostasis with the aim of identifying novel drug targets for the treatment of metabolic disorders such as type 2 diabetes
Commenting on Kei's new appointment, Sir Philip Cohen, the Director of the MRC Protein Phosphorylation Unit said:- 'Kei has done a great job for our Unit during the eight years that he has been with us. In addition to carrying out ground-breaking research of his own and important collaborative projects with other members of the Unit, he was also instrumental in setting up the Unit's state-of-the-art Molecular Physiology Laboratory. The huge promotion that Kei has now received is therefore very well deserved and we all wish him every success for the future.
Commenting on his new appointment Kei said:- 'I would particularly like to thank Professor Dario Alessi and Sir Philip Cohen for their tremendous support during my research career in Dundee, which was absolutely essential for me to become an independent and established investigator. The MRC Protein Phosphorylation Unit provides such an extraordinary stimulating, interactive and outstanding research environment with the state-of-art facilities, but I have decided to take on a new challenge and will make every effort to achieve breakthroughs in basic and translational research at the Nestle Institute in Lausanne.'
The Nestlé Institute of Health Sciences is based on the campus of the Swiss Federal Institute of Technology in Lausanne and part of Nestlé's global Research & Development network. It is fully funded by Nestlé, who will contribute 500 million Swiss francs to its development over the next 10 years. The mission of the Institute is [i]"To create and deliver world class excellence in biomedical research to better understand human health and ageing as influenced by genetics, metabolism and environment with the goal of translating this knowledge into personalized science-based nutrition".[/i] In Lausanne, Kei will continue to elucidate the molecular mechanisms that control glucose and energy homeostasis with the aim of identifying novel drug targets for the treatment of metabolic disorders such as type 2 diabetes